tracleer tablet 125 mg
johnson & johnson international (singapore) pte ltd - bosentan monohydrate 129.082mg eqv bosentan - tablet, film coated - 125 mg - bosentan monohydrate 129.082mg eqv bosentan 125 mg
tracleer tablet 62.5 mg
johnson & johnson international (singapore) pte ltd - bosentan monohydrate 64.541mg eqv bosentan - tablet, film coated - 62.5 mg - bosentan monohydrate 64.541mg eqv bosentan 62.5 mg
tracleer 125 mg
j-c health care ltd - bosentan - film coated tablets - bosentan 125 mg - bosentan - bosentan - treatment of pulmonary arterial hypertension (pah) in patients of who functional class ii-iv.reduction in the number of new digital ulcers in patients with systemic sclerosis with active digital ulcer disease
bosentan accord 62.5mg film-coated tablets
accord healthcare limited - bosentan - film-coated tablet - bosentan 62.5 mg - antihypertensives
bosentan accord 125mg film-coated tablets
accord healthcare limited - bosentan - film-coated tablet - bosentan 125 mg - antihypertensives
bosentan dr. reddy’s 62.5mg film-coated tablets
dr. reddy’s laboratories (uk) ltd. - bosentan - film-coated tablet - 62.5mg - other antihypertensives - treatment of pulmonary arterial hypertension (pah) to improve exercise capacity and symptoms in patients with who functional class iii. efficacy has been shown in: • primary (idiopathic and heritable) pulmonary arterial hypertension • pulmonary arterial hypertension secondary to scleroderma without significant interstitial pulmonary disease • pulmonary arterial hypertension associated with congenital systemic-topulmonary shunts and eisenmenger’s physiology
bosentan dr. reddy’s 125mg film-coated tablets
dr. reddy’s laboratories (uk) ltd. - bosentan - film-coated tablet - 125mg - other antihypertensives - treatment of pulmonary arterial hypertension (pah) to improve exercise capacity and symptoms in patients with who functional class iii. efficacy has been shown in: • primary (idiopathic and heritable) pulmonary arterial hypertension • pulmonary arterial hypertension secondary to scleroderma without significant interstitial pulmonary disease • pulmonary arterial hypertension associated with congenital systemic-topulmonary shunts and eisenmenger’s physiology
tracleer 62.5mg tablets
actelion pharmaceuticals uk ltd - bosentan monohydrate - tablet - 62.5mg
tracleer 125mg tablets
actelion pharmaceuticals uk ltd - bosentan monohydrate - tablet - 125mg
bosentan 62.5mg tablets
zentiva pharma uk ltd - bosentan monohydrate - oral tablet - 62.5mg